RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Yep, it is hard to predict when a pharma may or may not move and unlock the value in thier IP/drug discovery process.

A couple clues with the increasing volume/dilution the past 6 months and the new VP/debt settlement shares at .0015. Favorable debt terms pushed to Jan 2025. New VP agreement has weekly time expectation doubling next month per agreement in filing.

Assuming the OSA new drug formulation manufacturing is being worked on and close to prepping for clinical trials but no recent update there, and I am curious as to the status of listing Resolution Rx on ASX.

Assuming the KRM-II-81 in tier 3 of NIH pre clinical studies. Not sure how long those take, but I would speculate results sometime 2nd half of year judging by commentary and past timelines. As discussed here and mentioned by CEO "pursestrings" comment, I would think big pharma is seriously looking now and possibly looking at positioning with this drug candidate. Successful tier 3, likely yielding grant money leading into human clinicals would jump the valuation considerably.

I am invested and patient, so whether 6 days or 6 months or a year from now, I am will to take the risk and wait for that potential significant reward...